StockSelector.com
  Research, Select, & Monitor Thursday, July 27, 2017 12:33:31 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Aeglea Biotherapeutics, Inc.$3.59($.03)(.83%)

  Quote | Ranking | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Income Statement for Aeglea Biotherapeutics, Inc.
(Amounts are in millions) 12/2016 12/2015 12/2014
Press Release
Net Sales or Revenues $4.63 $6.09 $0.00
Cost of Goods Sold $0.00 $0.00 $0.00
Gross Profit $4.63 $6.09 $0.00
       
Research & Development Expense $18.14 $11.45 $6.83
Selling, General, & Admin. Expense $8.39 $5.95 $2.07
Income Before Depreciation ($21.91) ($11.32) ($8.90)
       
Depreciation, Depletion, Amortization $0.00 $0.00 $0.00
Non-Operating Income $0.21 $0.02 ($1.44)
Interest Expense $0.00 $0.00 $0.00
Pretax Income ($21.70) ($11.30) ($10.34)
       
Provision for Income Taxes $0.00 $0.00 $0.00
Minority Interest $0.00 $0.00 $0.00
Investment Gains (Losses) $0.00 $0.00 $0.00
Other Income $0.00 $0.00 $0.00
Income Before Extraordinaries ($21.70) ($11.30) ($10.34)
       
Extraordinary Items & Disc. Operations $0.00 $0.00 $0.00
Net Income ($21.70) ($11.30) ($10.34)
       
Basic Earnings Per Share ($2.22) ($19.21) N/A
Diluted Earnings Per Share ($2.22) ($19.21) N/A
       
Weighted Average Basic Shares Outstanding 9.79 N/A N/A
Weighted Average Diluted Shares Outstanding 9.79 N/A N/A
       
Income Before Non-Recurring Items ($21.70) N/A N/A
Income From Non-Recurring Items $0.00 N/A N/A
Diluted Earnings Per Share before extras ($2.22) N/A N/A
       
Dividend (preferred) N/A N/A N/A
Dividend (common) $0.00 N/A N/A
Dividend Per Share (common) $0.00 $0.00 $0.00




Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2017 StockSelector.com. All rights reserved.